Alkermes plc. Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value
Alkermes plc. (ALKS) had Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value of $401.04 million as of 2018-06-30, per its 10-Q filed 2018-07-26.
Discontinued › Notes › Investments › Debt and Equity Securities
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue · last filed 2018-07-26
- 2018-06-30: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value $401.04M.
- 2018-03-31: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value $351.80M.
- 2017-12-31: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value $395.74M.
- 2017-09-30: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value $400.14M.
| Period end | Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value as first filed |
|---|---|---|
| 2018-06-30 | $401.04M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $351.80M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $395.74M 10-K · filed 2018-02-16 | |
| 2017-09-30 | $400.14M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $399.20M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $404.67M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $429.41M 10-K · filed 2017-02-17 | |
| 2016-09-30 | $418.98M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $477.85M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $516.02M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $614.36M 10-K · filed 2016-02-25 | |
| 2015-09-30 | $591.54M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $633.85M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $594.78M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $575.96M 10-K · filed 2015-02-24 | |
| 2014-09-30 | $577.39M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $522.82M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $516.59M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $249.75M 10-KT · filed 2014-02-27 | |
| 2013-09-30 | $202.55M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $206.19M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $204.82M 10-K · filed 2013-05-23 | |
| 2012-09-30 | $100.99M 10-Q · filed 2013-01-31 | $73.36M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $137.59M 10-Q · filed 2012-07-26 | |
| 2012-03-31 | $154.00M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |